Morepen Laboratories eyeing multi-billion dollar global API market

12 Feb 2021 Evaluate

Morepen Laboratories is eyeing an all new multi-billion dollar global API (Active Pharmaceutical Ingredients) market with the addition of new molecules in its bulk drugs portfolio. The focus areas of these new molecules include chronic and lifestyle diseases like anti-diabetic, anti-hypertensive, cholesterol reducers and neuro-psychiatric. Global patent expiry for these new molecules is slated in next 5-6 years. These new molecules are currently under development and would come into play in phases over the next 24 to 36 months.

Morepen Laboratories is a well-known pharma company having well equipped Research & Development Centre and is all set to seize the Generic revolution in pharma industry, by filing multiple DMFs and COS for new APIs.

Morepen Laboratories Share Price

45.10 0.70 (1.58%)
16-Apr-2024 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1531.55
Dr. Reddys Lab 6003.15
Cipla 1379.40
Zydus Lifesciences 946.35
Lupin 1619.15
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.